Home Clinical Topics FDA approves new injectable drug for schizophrenia

FDA approves new injectable drug for schizophrenia

On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more 

LEAVE A REPLY

Please enter your comment!
Please enter your name here